Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement
暂无分享,去创建一个
M. Link | R. Hauer | H. Calkins | D. Corrado | F. Marchlinski | G. Thiene | C. Basso | A. Pelliccia | C. Schmied | T. Wichter | M. Paul | W. McKenna | F. Marcus | H. Tandri | F. Duru | N. Estes | C. Brunckhorst | A. Anastasakis | N. Protonotarios | A. Tsatsopoulou | B. Bauce
[1] T. Edvardsen,et al. Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members , 2014, European journal of heart failure.
[2] F. Marchlinski,et al. Ventricular tachycardia mapping and ablation in arrhythmogenic right ventricular cardiomyopathy/dysplasia: Lessons Learned. , 2014, World journal of cardiology.
[3] L. Mestroni,et al. Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy , 2014, Journal of Medical Genetics.
[4] M. Link,et al. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment. , 2014, Journal of the American College of Cardiology.
[5] L. Held,et al. Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasia. , 2014, The American journal of cardiology.
[6] S. Priori,et al. Missense Mutations in Plakophilin-2 Cause Sodium Current Deficit and Associate With a Brugada Syndrome Phenotype , 2014, Circulation.
[7] L. Held,et al. Different Prognostic Value of Functional Right Ventricular Parameters in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2014, Circulation. Cardiovascular imaging.
[8] D. Corrado,et al. Compound and Digenic Heterozygosity Predicts Lifetime Arrhythmic Outcome and Sudden Cardiac Death in Desmosomal Gene–Related Arrhythmogenic Right Ventricular Cardiomyopathy , 2013, Circulation. Cardiovascular genetics.
[9] Stefan L. Zimmerman,et al. Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.
[10] C. Semsarian,et al. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. , 2013, International journal of cardiology.
[11] S. Russell,et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.
[12] A. Schinkel. Implantable Cardioverter Defibrillators in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Patient Outcomes, Incidence of Appropriate and Inappropriate Interventions, and Complications , 2013, Circulation. Arrhythmia and electrophysiology.
[13] D. Corrado,et al. Prognostic Value of Endocardial Voltage Mapping in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2013, Circulation. Arrhythmia and electrophysiology.
[14] L. Held,et al. Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy. , 2013, The American journal of cardiology.
[15] S. Russell,et al. Risk Stratification in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy–Associated Desmosomal Mutation Carriers , 2012, Circulation. Arrhythmia and electrophysiology.
[16] Biykem Bozkurt,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[17] Wojciech Zareba,et al. Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.
[18] R. Hauer,et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy , 2012, European journal of heart failure.
[19] P. Kirchhof,et al. Can preload-reducing therapy prevent disease progression in arrhythmogenic right ventricular cardiomyopathy? Experimental evidence and concept for a clinical trial. , 2012, Progress in biophysics and molecular biology.
[20] T. Lüscher,et al. Predictors of Appropriate ICD Therapy in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy: Long Term Experience of a Tertiary Care Center , 2012, PloS one.
[21] S. Rizzo,et al. Intercalated disc abnormalities, reduced Na(+) current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes. , 2012, Cardiovascular research.
[22] S. Themistoclakis,et al. Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study. , 2012, Heart rhythm.
[23] M. Ackerman,et al. Videoscopic Left Cardiac Sympathetic Denervation for Patients With Recurrent Ventricular Fibrillation/Malignant Ventricular Arrhythmia Syndromes Besides Congenital Long-QT Syndrome , 2012, Circulation. Arrhythmia and electrophysiology.
[24] S. Russell,et al. Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2012, Circulation. Arrhythmia and electrophysiology.
[25] P. Vardas,et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia and troponin release. Myocarditis or the "hot phase" of the disease? , 2012, International journal of cardiology.
[26] F. Liang,et al. Connexin43 and the regulation of intercalated disc function. , 2012, Heart rhythm.
[27] D. Corrado,et al. Pathophysiology of arrhythmogenic cardiomyopathy , 2012, Nature Reviews Cardiology.
[28] D. Corrado,et al. Imaging Study of Ventricular Scar in Arrhythmogenic Right Ventricular Cardiomyopathy: Comparison of 3D Standard Electroanatomical Voltage Mapping and Contrast-Enhanced Cardiac Magnetic Resonance , 2012, Circulation. Arrhythmia and electrophysiology.
[29] J. Brugada,et al. Combined Endocardial and Epicardial Catheter Ablation in Arrhythmogenic Right Ventricular Dysplasia Incorporating Scar Dechanneling Technique , 2012, Circulation. Arrhythmia and electrophysiology.
[30] S. Russell,et al. Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2012, Journal of the American College of Cardiology.
[31] P. Lambiase,et al. Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study , 2012, European heart journal.
[32] F. Cuoco. Incidence and Predictors of Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Undergoing Implantable Cardioverter-Defibrillator Implantation for Primary Prevention , 2012 .
[33] Y. Oade,et al. Arrhythmogenic right ventricular cardiomyopathy , 2011, BMJ Case Reports.
[34] Brian R. Anderson,et al. Genetic Variation in Titin in Arrhythmogenic Right Ventricular Cardiomyopathy–Overlap Syndromes , 2011, Circulation.
[35] P. Elliott,et al. Familial Evaluation in Arrhythmogenic Right Ventricular Cardiomyopathy: Impact of Genetics and Revised Task Force Criteria , 2011, Circulation.
[36] L. Mestroni,et al. Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. , 2011, European heart journal.
[37] D. Corrado,et al. Controversies in cardiovascular medicine Risk of sports : do we need a pre-participation screening for competitive and leisure athletes ? , 2011 .
[38] G. Thiene,et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia on the basis of the revised diagnostic criteria in affected families with desmosomal mutations , 2011, European heart journal.
[39] G. Breithardt,et al. Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. , 2011, Journal of the American College of Cardiology.
[40] J. Bates,et al. Circ Arrhythm Electrophysiol , 2011 .
[41] M. Link,et al. Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular Tachycardia , 2010, Circulation.
[42] C. Basso,et al. Pitfalls in the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. , 2010, The American journal of cardiology.
[43] L. Jordaens,et al. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Diagnostic Task Force Criteria: Impact of New Task Force Criteria , 2010, Circulation. Arrhythmia and electrophysiology.
[44] Wojciech Zareba,et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.
[45] John C Chambers,et al. Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. , 2010, Annual review of medicine.
[46] J. Moolman-Smook,et al. Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa. , 2009, Heart rhythm.
[47] G. Guerrero-Serna,et al. Loss of Plakophilin-2 Expression Leads to Decreased Sodium Current and Slower Conduction Velocity in Cultured Cardiac Myocytes , 2009, Circulation research.
[48] G. Marcus,et al. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. , 2009, Journal of the American College of Cardiology.
[49] F. Marchlinski,et al. Epicardial Substrate and Outcome With Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2009, Circulation.
[50] F. Duru,et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare “disease of the desmosome” with multiple clinical presentations , 2009, Clinical Research in Cardiology.
[51] V. Barrios,et al. Arrhythmogenic right ventricular dysplasia. , 2009, Journal of the American College of Cardiology.
[52] Dudley J Pennell,et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. , 2008, Journal of the American College of Cardiology.
[53] A. Nogami,et al. Changes in the Isolated Delayed Component as an Endpoint of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy: Predictor for Long‐Term Success , 2008, Journal of cardiovascular electrophysiology.
[54] Sean Connors,et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. , 2008, American journal of human genetics.
[55] D. Corrado,et al. Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. , 2008, Journal of the American College of Cardiology.
[56] P. Syrris,et al. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2007, Journal of the American College of Cardiology.
[57] S. Russell,et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2007, Journal of the American College of Cardiology.
[58] S. Peters. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres , 2007, Journal of cardiovascular medicine.
[59] A novel treatment strategy for therapy refractory ventricular arrhythmias in the setting of arrhythmogenic right ventricular dysplasia. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[60] Petros Syrris,et al. Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression , 2007, Circulation.
[61] G. Boriani,et al. Outcome of cardioverter–defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy , 2007, Heart and Vessels.
[62] D. Pennell,et al. Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. , 2006, Journal of the American College of Cardiology.
[63] G. Breithardt,et al. Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice , 2006, Circulation.
[64] Maurizio Schiavon,et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. , 2006, JAMA.
[65] A. Biederman,et al. Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[66] W. Shimizu,et al. Catheter Ablation of Stable and Unstable Ventricular Tachycardias in Patients with Arrhythmogenic Right Ventricular Dysplasia , 2006, Journal of cardiovascular electrophysiology.
[67] D. Corrado,et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. , 2006, Circulation.
[68] S. Russell,et al. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. , 2005, Heart rhythm.
[69] E. Aliot,et al. Electroanatomic mapping characteristics of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. , 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[70] K. Lemola,et al. Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre , 2005, Heart.
[71] G. Danieli,et al. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. , 2005, European heart journal.
[72] A. Verma,et al. Short- and Long-Term Success of Substrate-Based Mapping and Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia , 2005, Circulation.
[73] J. Bourke,et al. Right ventricular disarticulation. An 18-year single centre experience. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[74] S. Russell,et al. Arrhythmogenic Right Ventricular Dysplasia: A United States Experience , 2005, Circulation.
[75] A. Bassett,et al. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). , 2005, Journal of the American College of Cardiology.
[76] Gian Antonio Danieli,et al. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. , 2005, Cardiovascular Research.
[77] S. Sen-Chowdhry,et al. Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. , 2004, The American journal of medicine.
[78] A. Russo,et al. Electroanatomic Substrate and Outcome of Catheter Ablative Therapy for Ventricular Tachycardia in Setting of Right Ventricular Cardiomyopathy , 2004, Circulation.
[79] X. Jouven,et al. Natural History and Risk Stratification of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2004, Circulation.
[80] H. Halperin,et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2004, Journal of the American College of Cardiology.
[81] G. Breithardt,et al. Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy: Single-Center Experience of Long-Term Follow-Up and Complications in 60 Patients , 2004, Circulation.
[82] Paul J. Wang,et al. Arrhythmogenic Right Ventricular Dysplasia: Clinical Results with Implantable Cardioverter Defibrillators , 1997, Journal of Interventional Cardiac Electrophysiology.
[83] M. Link,et al. Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2003, Circulation.
[84] Maurizio Schiavon,et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.
[85] G. Steinbeck,et al. Electroanatomic Mapping of Endocardial Right Ventricular Activation as a Guide for Catheter Ablation in Patients with Arrhythmogenic Right Ventricular Dysplasia , 2003, Pacing and clinical electrophysiology : PACE.
[86] Jeffrey A Feinstein,et al. Electrical Resynchronization: A Novel Therapy for the Failing Right Ventricle , 2003, Circulation.
[87] A. Carpentier,et al. Right ventricular cardiomyoplasty: 10-year follow-up. , 2003, The Annals of thoracic surgery.
[88] D. Stephan,et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.
[89] L. Jordaens,et al. Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias , 2001, Heart.
[90] G. Danieli,et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. , 2000, Journal of the American College of Cardiology.
[91] R. Frank,et al. Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: A 16-year experience , 2000, Current cardiology reports.
[92] D. Corrado,et al. CARDIOMYOPATHY Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment , 2022 .
[93] G. Breithardt,et al. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy : quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. , 2000, Circulation.
[94] W. Stevenson,et al. Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. , 1998, Journal of the American College of Cardiology.
[95] M. Davies,et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. , 1997, Journal of the American College of Cardiology.
[96] A. Angelini,et al. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? , 1996, Circulation.
[97] G Thiene,et al. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. , 1994, Human molecular genetics.
[98] H. Scheld,et al. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. , 1994, American heart journal.
[99] A. Nava,et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.
[100] G. Breithardt,et al. Regional Myocardial Sympathetic Dysinnervation in Arrhythmogenic Right Ventricular Cardiomyopathy: An Analysis Using 123I‐Meta‐Iodobenzylguanidine Scintigraphy , 1994, Circulation.
[101] G. Breithardt,et al. Efficacy of Antiarrhythmic Drugs in Patients With Arrhythmogenic Right Ventricular Disease: Results in Patients With Inducible and Noninducible Ventricular Tachycardia , 1992, Circulation.
[102] D. Corrado,et al. Right ventricular cardiomyopathy: is there evidence of an inflammatory aetiology? , 1991, European heart journal.
[103] D. Corrado,et al. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. , 1990, The American journal of medicine.
[104] G. Fontaine,et al. Electrode catheter ablation of resistant ventricular tachycardia in arrhythmogenic right ventricular dysplasia: experience of 13 patients with a mean follow-up of 45 months. , 1989, European heart journal.
[105] J. Gallagher,et al. Long-term follow-up in patients with arrhythmogenic right ventricular disease. , 1989, European heart journal.
[106] D. Corrado,et al. Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.
[107] S. Olsson,et al. A long term follow up of 15 patients with arrhythmogenic right ventricular dysplasia. , 1987, British heart journal.
[108] R Frank,et al. Right Ventricular Dysplasia: A Report of 24 Adult Cases , 1982, Circulation.